Taku Tsukidate

Merck & Co., Inc., Rahway, NJ, USA (United States)

Biochemistry, Genetics and Molecular BiologyChemistryMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Small molecule modulators of immune pattern recognition receptors”.

Small molecule modulators of immune pattern recognition receptors

RSC Chemical Biology(2023)10.1039/d3cb00096f

N/A

0DataRank · unranked

22 citations

Charles W. Hespen, Howard C. Hang, Taku Tsukidate

N-Arylpyrazole NOD2 Agonists Promote Immune Checkpoint Inhibitor Therapy

ACS Chemical Biology(2023)10.1021/acschembio.3c00085

N/A

0DataRank · unranked

11 citations

Taku Tsukidate, Howard C. Hang, Matthew E. Griffin

N -arylpyrazole NOD2 agonists promote immune checkpoint inhibitor therapy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.26.525573

N/A

0DataRank · unranked

0 citations

Taku Tsukidate, Howard C. Hang, Matthew E. Griffin